$0.4488
0.0245.65%
Last update: Nov 6, 9:00 AM
Oncolytics Biotech Inc
ONCYNASDAQ
The average analyst price target for Oncolytics Biotech is $4.67, 961.4% above the current price. Of 6 analysts, 5 rate it Buy and 1 Hold. Targets range from $3 to $7. The latest change came on Aug 19, 2026, when HC Wainwright & Co. lowered its price target on Oncolytics Biotech from $10 to $5 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
